Boston Scientific Corporation
General ticker "BSX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $132.5B
Boston Scientific Corporation follows the US Stock Market performance with the rate: 68.0%.
Estimated limits based on current volatility of 1.1%: low 87.91$, high 89.86$
Factors to consider:
- Company included in S&P500 list
- Current price 23.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [51.26$, 72.23$]
- 2024-12-30 to 2025-12-30 estimated range: [61.30$, 84.19$]
Financial Metrics affecting the BSX estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 2.05
- Positive: 9.05 < Operating profit margin, % of 16.45
- Positive: Interest expense per share, $ of 0.18 <= 0.74
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 4.36
- Negative: 0 < Industry inventory ratio change (median), % of 0.19
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: -3.48 < Investing cash flow per share, $ of -1.77
Short-term BSX quotes
Long-term BSX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $11,966.00MM | $12,660.00MM | $14,240.00MM |
| Operating Expenses | $10,767.00MM | $11,011.00MM | $11,897.00MM |
| Operating Income | $1,199.00MM | $1,649.00MM | $2,343.00MM |
| Non-Operating Income | $-123.00MM | $-508.00MM | $-358.00MM |
| Interest Expense | $341.00MM | $470.00MM | $265.00MM |
| R&D Expense | $1,204.00MM | $1,323.00MM | $1,414.00MM |
| Income(Loss) | $1,076.00MM | $1,141.00MM | $1,985.00MM |
| Taxes | $36.00MM | $443.00MM | $393.00MM |
| Profit(Loss) | $1,040.00MM | $698.00MM | $1,592.00MM |
| Stockholders Equity | $16,623.00MM | $17,574.00MM | $19,282.00MM |
| Inventory | $1,610.00MM | $1,867.00MM | $2,484.00MM |
| Assets | $32,230.00MM | $32,470.00MM | $34,887.00MM |
| Operating Cash Flow | $1,870.00MM | $1,526.00MM | $2,503.00MM |
| Capital expenditure | $554.00MM | $612.00MM | $800.00MM |
| Investing Cash Flow | $-1,597.00MM | $-2,011.00MM | $-2,574.00MM |
| Financing Cash Flow | $-95.00MM | $-548.00MM | $5.00MM |
| Earnings Per Share* | $0.69 | $0.45 | $1.08 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.